24
Participants
Start Date
May 31, 2018
Primary Completion Date
June 30, 2021
Study Completion Date
August 31, 2021
Methylene Blue
Administration of methylene blue as per the treating physician's diagnosis and the acute care facility's standard of care
New York Methodist, New York
University of Pittsburgh, Pittsburgh
Einstein Medical Center, Philadelphia
University of Maryland, Baltimore
Carolinas Medical Center, Charlotte
Palmetto General, Palm Beach Gardens
Tampa General, Tampa
University of Tennessee Health Science Center, Memphis
University Hospitals, Cleveland
Mercy Health, Youngstown
University of Cincinnati, Cincinnati
IU Health, Indianapolis
Henry Ford Health System, Detroit
St John Medical Center, Detroit
University of Iowa, Iowa City
Medical College of Wisconsin, Milwaukee
HealthPartners Regions, Saint Paul
Washington University, St Louis
University of Kansas Health System, Kansas City
University of Nebraska, Omaha
UT Southwestern, Dallas
Baylor College of Medicine, Houston
Houston Methodist, Houston
Cedars Sinai, Los Angeles
UC Davis Health, Sacramento
Oregon Health & Sciences University, Portland
University of Washington, Seattle
Bridgeport Hospital, Bridgeport
Hartford Hospital, Hartford
Partners Healthcare; Brigham and Women's, Boston
UMass Memorial Medical Center, Worcester
Holy Name Medical Center, Teaneck
Prove pharm
INDUSTRY
Hospital Quality Foundation
OTHER